Table 1.
Clinicopathological characteristics of colorectal carcinoma patients
N=348 | NR (N=38) | NI (N=43) | NP (N=267) | P value |
---|---|---|---|---|
Age (years) | 68.97±14.95 | 67.26±12.64 | 63.95±14.17 | 0.0625 |
Sex | 0.7167 | |||
Male | 16 (42.11%) | 22 (51.16%) | 126 (47.19%) | |
Female | 22 (57.89%) | 21 (48.84%) | 141 (52.81%) | |
Histological grade | 0.0222 | |||
Low | 21 (55.26%) | 34 (79.07%) | 201 (75.28%) | |
High | 17 (44.74%) | 9 (20.93%) | 66 (24.72%) | |
Tumour location | 0.0025 | |||
Left | 1 1 (28.95%) | 26 (60.47%) | 155 (58.05%) | |
Right | 27 (71.05%) | 17 (39.53%) | 112 (41.95%) | |
TNM stage | 0.0346 | |||
I | 2 (5.26%) | 1 1 (25.58%) | 57 (21.35%) | |
II | 16 (42.11%) | 9 (20.93%) | 100 (37.45%) | |
III | 19 (50%) | 22 (51.16%) | 94 (35.21%) | |
IV | 1 (2.63%) | 1 (2.33%) | 16 (5.99%) | |
MMR status | 0.0027 | |||
Proficient | 20 (52.63%) | 34 (79.07%) | 208 (77.90%) | |
Deficient | 18 (47.37%) | 9 (20.93%% | 59 (22.10%) |
MMR, mismatch repair; NI, neutrophil-intermediate; NP, neutrophil-poor; NR, neutrophil-rich; TNM, tumour, node, metastasis.